An oral-to-urinalysis fluorescent prodrug platform for IBD theranostics.

We developed an oral-to-urinalysis theranostic approach for inflammatory bowel disease (IBD) that aims to improve procedural practicality and safety by enabling diagnosis and treatment monitoring without invasive sampling. The strategy exploits disea…

Preview only. Read the full abstract at the source